Consulting Services
Compare Stocks
2 / 10Stock Comparison
EXPO vs FCN
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
EXPO vs FCN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consulting Services | Consulting Services |
| Market Cap | $3.12B | $4.87B |
| Revenue (TTM) | $582M | $3.87B |
| Net Income (TTM) | $106M | $267M |
| Gross Margin | 40.1% | 31.8% |
| Operating Margin | 20.6% | 10.2% |
| Forward P/E | 30.9x | 17.3x |
| Total Debt | $83M | $590M |
| Cash & Equiv. | $222M | $265M |
EXPO vs FCN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Exponent, Inc. (EXPO) | 100 | 85.5 | -14.5% |
| FTI Consulting, Inc. (FCN) | 100 | 134.4 | +34.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPO vs FCN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 13 yrs, beta 0.89, yield 1.9%
- Rev growth 4.2%, EPS growth -1.9%, 3Y rev CAGR 4.3%
- Lower volatility, beta 0.89, Low D/E 21.2%, current ratio 2.40x
FCN is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 294.4% 10Y total return vs EXPO's 186.1%
- PEG 2.23 vs EXPO's 5.18
- Beta 0.09, current ratio 1.56x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.2% revenue growth vs FCN's 2.4% | |
| Value | Lower P/E (17.3x vs 30.9x), PEG 2.23 vs 5.18 | |
| Quality / Margins | 18.2% margin vs FCN's 6.9% | |
| Stability / Safety | Beta 0.09 vs EXPO's 0.89 | |
| Dividends | 1.9% yield; 13-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -2.0% vs EXPO's -13.6% | |
| Efficiency (ROA) | 13.7% ROA vs FCN's 7.6%, ROIC 36.3% vs 15.9% |
EXPO vs FCN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXPO vs FCN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EXPO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FCN is the larger business by revenue, generating $3.9B annually — 6.7x EXPO's $582M. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to FCN's 6.9%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $582M | $3.9B |
| EBITDAEarnings before interest/tax | $125M | $445M |
| Net IncomeAfter-tax profit | $106M | $267M |
| Free Cash FlowCash after capex | $122M | $318M |
| Gross MarginGross profit ÷ Revenue | +40.1% | +31.8% |
| Operating MarginEBIT ÷ Revenue | +20.6% | +10.2% |
| Net MarginNet income ÷ Revenue | +18.2% | +6.9% |
| FCF MarginFCF ÷ Revenue | +21.0% | +8.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.8% | +9.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.5% | +4.0% |
Valuation Metrics
FCN leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 19.6x trailing earnings, FCN trades at a 36% valuation discount to EXPO's 30.6x P/E. Adjusting for growth (PEG ratio), FCN offers better value at 2.53x vs EXPO's 5.15x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.1B | $4.9B |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | 30.65x | 19.64x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.87x | 17.32x |
| PEG RatioP/E ÷ EPS growth rate | 5.15x | 2.53x |
| EV / EBITDAEnterprise value multiple | 22.99x | 11.21x |
| Price / SalesMarket cap ÷ Revenue | 5.37x | 1.29x |
| Price / BookPrice ÷ Book value/share | 8.33x | 3.07x |
| Price / FCFMarket cap ÷ FCF | 25.54x | 31.13x |
Profitability & Efficiency
EXPO leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
EXPO delivers a 25.5% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $15 for FCN. EXPO carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to FCN's 0.34x. On the Piotroski fundamental quality scale (0–9), EXPO scores 6/9 vs FCN's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +25.5% | +15.1% |
| ROA (TTM)Return on assets | +13.7% | +7.6% |
| ROICReturn on invested capital | +36.3% | +15.9% |
| ROCEReturn on capital employed | +19.2% | +16.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.21x | 0.34x |
| Net DebtTotal debt minus cash | -$139M | $324M |
| Cash & Equiv.Liquid assets | $222M | $265M |
| Total DebtShort + long-term debt | $83M | $590M |
| Interest CoverageEBIT ÷ Interest expense | — | 28.20x |
Total Returns (Dividends Reinvested)
FCN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FCN five years ago would be worth $11,256 today (with dividends reinvested), compared to $7,147 for EXPO. Over the past 12 months, FCN leads with a -2.0% total return vs EXPO's -13.6%. The 3-year compound annual growth rate (CAGR) favors FCN at -2.8% vs EXPO's -8.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.1% | -5.0% |
| 1-Year ReturnPast 12 months | -13.6% | -2.0% |
| 3-Year ReturnCumulative with dividends | -24.4% | -8.2% |
| 5-Year ReturnCumulative with dividends | -28.5% | +12.6% |
| 10-Year ReturnCumulative with dividends | +186.1% | +294.4% |
| CAGR (3Y)Annualised 3-year return | -8.9% | -2.8% |
Risk & Volatility
FCN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FCN is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than EXPO's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FCN currently trades 85.5% from its 52-week high vs EXPO's 77.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.09x |
| 52-Week HighHighest price in past year | $81.95 | $189.30 |
| 52-Week LowLowest price in past year | $63.25 | $149.31 |
| % of 52W HighCurrent price vs 52-week peak | +77.4% | +85.5% |
| RSI (14)Momentum oscillator 0–100 | 38.6 | 28.1 |
| Avg Volume (50D)Average daily shares traded | 452K | 426K |
Analyst Outlook
EXPO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates EXPO as "Buy" and FCN as "Buy". Consensus price targets imply 34.0% upside for EXPO (target: $85) vs 2.6% for FCN (target: $166). EXPO is the only dividend payer here at 1.89% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $85.00 | $166.00 |
| # AnalystsCovering analysts | 8 | 13 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | — |
| Dividend StreakConsecutive years of raises | 13 | 0 |
| Dividend / ShareAnnual DPS | $1.20 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +17.6% |
EXPO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FCN leads in 3 (Valuation Metrics, Total Returns).
EXPO vs FCN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EXPO or FCN a better buy right now?
For growth investors, Exponent, Inc.
(EXPO) is the stronger pick with 4. 2% revenue growth year-over-year, versus 2. 4% for FTI Consulting, Inc. (FCN). FTI Consulting, Inc. (FCN) offers the better valuation at 19. 6x trailing P/E (17. 3x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPO or FCN?
On trailing P/E, FTI Consulting, Inc.
(FCN) is the cheapest at 19. 6x versus Exponent, Inc. at 30. 6x. On forward P/E, FTI Consulting, Inc. is actually cheaper at 17. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: FTI Consulting, Inc. wins at 2. 23x versus Exponent, Inc. 's 5. 18x.
03Which is the better long-term investment — EXPO or FCN?
Over the past 5 years, FTI Consulting, Inc.
(FCN) delivered a total return of +12. 6%, compared to -28. 5% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: FCN returned +294. 4% versus EXPO's +186. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPO or FCN?
By beta (market sensitivity over 5 years), FTI Consulting, Inc.
(FCN) is the lower-risk stock at 0. 09β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 890% more volatile than FCN relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 34% for FTI Consulting, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXPO or FCN?
By revenue growth (latest reported year), Exponent, Inc.
(EXPO) is pulling ahead at 4. 2% versus 2. 4% for FTI Consulting, Inc. (FCN). On earnings-per-share growth, the picture is similar: FTI Consulting, Inc. grew EPS 5. 5% year-over-year, compared to -1. 9% for Exponent, Inc.. Over a 3-year CAGR, FCN leads at 7. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPO or FCN?
Exponent, Inc.
(EXPO) is the more profitable company, earning 18. 2% net margin versus 7. 1% for FTI Consulting, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 10. 9% for FCN. At the gross margin level — before operating expenses — FCN leads at 32. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPO or FCN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, FTI Consulting, Inc. (FCN) is the more undervalued stock at a PEG of 2. 23x versus Exponent, Inc. 's 5. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, FTI Consulting, Inc. (FCN) trades at 17. 3x forward P/E versus 30. 9x for Exponent, Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EXPO: 34. 0% to $85. 00.
08Which pays a better dividend — EXPO or FCN?
In this comparison, EXPO (1.
9% yield) pays a dividend. FCN does not pay a meaningful dividend and should not be held primarily for income.
09Is EXPO or FCN better for a retirement portfolio?
For long-horizon retirement investors, FTI Consulting, Inc.
(FCN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09), +294. 4% 10Y return). Both have compounded well over 10 years (FCN: +294. 4%, EXPO: +186. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPO and FCN?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
EXPO pays a dividend while FCN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.